SUMMARY Beta-thromboglobulin is a platelet specific protein which is released from platelets during the platelet release reaction. The amount of f8-thromboglobulin released during various conditions of in vitro storage, including cryopreservation, was compared. The results suggest the measurement of f3-thromboglobulin is unlikely to be of use as a quality control assay for monitoring the in vitro viability of stored platelets.
Platelet concentrates (PCS) are now routinely stored in vitro at 22°C although there has been much controversy as to whether they should be stored at 4°C, 22°C or cryopreserved. None of these storage conditions is ideal. '-9 The platelet specific proteins, /3-thromboglobulin (,8TG), low-affinity platelet factor 4 and platelet factor 4 (PF4), are stored in the alpha granules and are released from platelets during the platelet release reaction which normally occurs after platelet aggregation.'0-12, TG appears to be a proteolytic product of low-affinity platelet factor 413 The cryopreserved platelets were thawed at 37°C in a waterbath and assayed without removal of cryoprotectant.
A maximum releasable ,BTG value in a given PC was obtained by freezing a sample in liquid nitrogen in the absence of cryoprotective agent and thawing at 37°C. The freeze-thaw process was repeated three times before dilution of the sample 1/10 with PBS pH 7-3 containing 1% (vol/vol) Triton X-100. The sample was sonicated for 30 s in a sonicator (MSE Scientific Instruments, Crawley, West Sussex). An aliquot of the sonicated sample (2-5 ml) was processed and assayed for ,BTG content as described above.
To determine f3TG release after thrombininduced platelet aggregation one volume of ACD was added to eight volumes of PC and the sample centrifuged at 900 g for 15 min at room temperature in an MSE Minor Centrifuge. The button was resuspended in modified Tyrode's solution (0.15 M NaCI, 3 mM KCI, 0-1 M NaHCO3, 0-3 mM NaH2 P04, 5 mM glucose pH 7.35) to give the same platelet count as that of the PC in autologous plasma. In the aggregation assays19 an amount of thrombin (human, 10 U/ml Sigma Chemical Co Ltd, Poole, Dorset) sufficient to give maximum aggregation (approximately 100 ILI/ml platelet concentrate) was added. When sedimentation of the aggregate had occurred (approximately 2 min) an aliquot of the supematant material was processed and assayed for /3TG content as described above.
Statistical analysis of the results was carried out using Student's t test.
Results
The results obtained for PCS stored at 4°C or 22°C for 48 h are shown in Fig. 1 However, further work is required to establish whether the results are due to the anticoagulant or the centrifugation conditions and may indicate whether the centrifugation conditions used during platelet preparation significantly influence the release of (3TG.
The release of three cytoplasmic enzymes (nucleoside diphosphokinase, 3-phosphoglycerate kinase and enolase) during preparation of PCS has been studied by Mourad and Pert25 who found that there was a greater release of these enzymes during the preparation of concentrates from whole blood collected in CPD anticoagulant (pH 7-3) than when the anticoagulant was ACD (pH 6.9). Furthermore, reduction of the pH by addition of extra anticoagulant (pH 6.65) caused a corresponding decrease in the averaged values for the amount of the three enzymes released which is similar to the findings reported here for ,TG (Fig. 1) The results obtained here (Fig. 2) show that cryopreservation in 5 % DMSO releases less fTG than cryopreservation in 3% glucose 3% glycerol and are in general agreement with those obtained previously using other in vitro assays (hypotonic shock response and serotonin uptake) which suggested that 5 % DMSO is the most satisfactory cryoprotective agent. 
